Literature DB >> 954650

Participation of serotonin in the phasic release of LH. I. Evidence from pharmacological experiments.

M Héry, E Laplante, C Kordon.   

Abstract

Subcutaneous implantation of a silastic tubing containing crystalline estradiol in castrated female rats results in a circadian rhythm of LH release. Under such conditions, blockade of serotonin (5-HT) biosynthesis by p-chlorophenylalanine (PCPA) completely inhibits the afternoon elevation of plasma LH. Gonadotropin peaks remain inhibited as long as the concentration of the transmitter is effectively depleted. Intraperitoneal administration or intraventricular infusion of minute doses of the immediate precursor of the amine, 5-hydroxytryptophan (5-HTP), results in the reappearance of the next afternoon rise of plasma gonadotropin, whenever hypothalamic levels of 5-hydroxyindole acetic acid (5-HIAA), the main metabolite of 5-HT, are significantly increased over their value in PGPA-treated animals. The administration of methiothepin, a 5-HT receptor blocker, 9 hours of more prior to the next expected LH rise, similarly inhibits the cycle, whereas a dopamine receptor inhibitor has no effect under the same time conditions. We have concluded that serotoninergic neuron systems can have a positive, permissive effect on the transfer of neural information resulting in phasic gonadotropin release; this action of the amine is different from, but not contradictory to, the known inhibitory effect of 5-HT on the release of LHRH from the median eminence.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954650     DOI: 10.1210/endo-99-2-496

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Enhancement of melatonin's antigonadal action by daily injections of the serotonin uptake inhibitor fluoxetine in male hamsters.

Authors:  J M Olcese
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

Review 2.  Progress in neuroendocrinology: LH releasing (LHRH), basic and clinical aspects.

Authors:  S M McCann
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

3.  Synchronizing role of serotonin in regulation of pituitary gonadotropic function in female rats.

Authors:  V N Babichev; E I Adamskaya
Journal:  Neurosci Behav Physiol       Date:  1983 Mar-Apr

4.  Anatomical relationships of serotoninergic and noradrenalinergic projections with the GnRH system in septum and hypothalamus.

Authors:  L Jennes; W C Beckman; W E Stumpf; R Grzanna
Journal:  Exp Brain Res       Date:  1982       Impact factor: 1.972

Review 5.  Ontogenic studies of the neural control of adenohypophyseal hormones in the rat: gonadotropins.

Authors:  D Becú-Villalobos; I M Lacau-Mengido; C Libertun
Journal:  Cell Mol Neurobiol       Date:  1990-12       Impact factor: 5.046

6.  Localization of serotonin in the hypothalamus and the mesencephalon of the guinea-pig. An immunohistochemical study using monoclonal antibodies.

Authors:  M Warembourg; P Poulain
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

Review 7.  Development of gonadotropin-releasing hormone (GnRH) neuron regulation in the female rat.

Authors:  D Becú-Villalobos; C Libertun
Journal:  Cell Mol Neurobiol       Date:  1995-02       Impact factor: 5.046

8.  Effect of melatonin on induction of ovulation in the light- induced constant estrous-anovulatory syndrome and possible role of the brain serotoninergic system.

Authors:  G P Trentini; B Mess; C F De Gaetani; C Ruzsás
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

9.  Effects of chemical lesion of the ventral noradrenergic bundle or the medial preoptic area on preovulatory LH release in rats.

Authors:  J L Hancke; W Wuttke
Journal:  Exp Brain Res       Date:  1979-03-09       Impact factor: 1.972

10.  Effect of acute and chronic 17 beta-estradiol treatment on serotonin and 5-hydroxyindole acetic acid content of discrete brain nuclei of ovariectomized rat.

Authors:  T Di Paolo; M Diagle; V Picard; N Barden
Journal:  Exp Brain Res       Date:  1983       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.